Banks for Your Business, Interview

The Fintech Mag Interview James Simcox, Chief Product Officer of Equals Group | The Challenges and Achievements of launching a BaaS product for Equals Money

With a range of experience in the finance and consumer goods sectors respectively, James Simcox is the Chief Product Officer of Equals Group, an AIM-listed fintech. James leads the product, design pre-sales and implementation teams, along with international business, to deliver financial solutions to businesses across the world. James worked alongside the COO to launch the Equals Enterprise Solutions Business (BaaS) which has grown to more than 30% of Equals Group’s revenue.

We caught up with James to gain a deeper understanding of why he felt launching a BaaS product was so important for Equals Money and their clients.

 

THE FINTECH MAG – Can you explain the key benefits of BaaS for businesses, particularly those outside of the traditional banking sector?

JAMES SIMCOX – BaaS offers several vital benefits for all kinds of businesses. I think the avoidance of licensing and legal obstacles is one of the key advantages, whether your business is in the banking sector or not.

Through open banking and API leveraging, businesses can seamlessly embed BaaS solutions into their existing products. This integration allows banks to adopt fintech innovations while businesses incorporate banking functionalities, effectively merging two separate worlds to benefit both parties financially and operationally.

BaaS also offers businesses mass acceleration on go-to-market speed as their cross-border, multicurrency banking services will be implemented without the need for a lengthy build.

As a result, businesses often see increased usage of their core propositions due to the enhanced customer volume. We find our customers are less likely to go elsewhere when we can offer them everything they need, all in one place.

 

THE FINTECH MAG – Please give us an overview of Equals Money’s new BaaS offering and what it means for your clients

JAMES SIMCOX – Our BaaS product is a significant milestone for us, reinforcing our commitment to delivering comprehensive financial solutions to our customers. Essentially, by leveraging the Equals Money’s API, businesses can take advantage of custom-branded cards, global payments and multi-currency accounts.

We offer International Bank Account Numbers for up to 38 currencies within a single account, facilitating international and domestic payments through Swift, UK Fater Payments, SEPA and SEPA Instant. This means businesses get paid faster without the hassle of handling multiple bank accounts. Our clients will be able to offer their customers all these amazing benefits wrapped up in a white labelled product, personalised to their own branding. Through white labelling, our BaaS product allows our customers to expand their core product offerings – so it’s a win win.

 

THE FINTECH MAG – What makes Equals Money best placed to offer this service?

JAMES SIMCOX – Equals Money is unique in the BaaS space. Our turn-key solution allows customers to use our infrastructure through our API, front-end, or a combination of both, facilitating a level of flexibility that is rare in the industry.

In Europe, we stand out as one of the few providers offering multi-currency, cross-border payment account products. We tend to find that whilst other providers may focus on niche markets, Equals Money covers the entire spectrum.

For customers looking to launch their own banking product with us, we can immediately provide access to 32 markets. This expansive reach from the beginning significantly enhances their ability to scale and grow.

 

THE FINTECH MAG – Why did Equals Money decide now was the time to expand into BaaS?

JAMES SIMCOX – The demand for on-demand, digital services is continually increasing. Expanding into BaaS felt like a natural progression to meet these growing expectations, as people and businesses increasingly desire services that are accessible at their fingertips.

Convenience is also key for our customers. By integrating banking products directly into their services, we have found our customers can significantly enhance their user experience.

Then looking holistically, continuing to diversify our market allows us to broaden our service portfolio. This not only meets growing demand but also positions us as the versatile and innovative provider within the industry.

 

THE FINTECH MAG – Please share some examples of how your current BaaS customers have benefitted.

JAMES SIMCOX – Absolutely. Our expansion into BaaS has already garnered significant interest, and we’re thrilled to see the positive impact on our customers.

Two of our first customers are CASHét, a renowned film services payments provider, and Chorus TM, a global treasury management solution for the music and entertainment sector.

Let’s take Chorus TM as our example, a collaboration that saves money for their entertainment clients while simplifying the work for the teams behind them. The new Chorus TM platform delivers a range of benefits to entertainment managers, including fast and secure UK and international payments, real-time spend reporting, streamlined reconciliation processes, and effective FX management strategies. By providing virtual cards as an alternative to traditional credit card payments, the platform enables quick and secure transactions and offers real-time visibility over expenditures.

This is just one example of how our BaaS offering is making a tangible difference for our customers.

 

Enhancing services. Streamlining Operations.

As we’ve heard from James, by offering BaaS, Equals Money have provided significant value to their customers, whilst boosting their revenue also. James is relentless in driving forward the vision of Equals Money as the comprehensive, efficient service provider of financial solutions.

For businesses looking to streamline their financial operations whilst enhancing their service offerings, Equals Money presents a great opportunity. Reach out to learn how Equals Money can tailor its services to your business’s specific needs.

PostAd_coinrule_banner728x90

Leave a Comment

Your email address will not be published. Required fields are marked *

*

Equasens: 2024 half-year results

2024-09-27T16:00:00Z

Villers-lès-Nancy, 27 September 2024 - 6:00 p.m. (CET)

PRESS RELEASE

2024 half-year results

  • Group results impacted by weaker economic conditions and continuing investment efforts in H1:
    • Revenue: €108.0m, -4.1%
    • Current Operating Income: €20.9m, -24.1%
  • Net Profit attributable to the Group: €17.2m, -21.8%
  • Though with a profit margin that continues to be very positive:
    • Ratio of Current Operating Income (COI) to Sales: 19.3% on a reported basis and 20.0% like-for-like
H1 RESULTS (€M)2023
reported basis
2024
reported basis
Change / Reported basisExternal growthChange / Like-for-like basis
Revenue112.6108.0-4.6-4.1%-3.7-8.3-7.4%
Current operating income (COI)27.520.9-6.6-24.1%0.0-6.7-24.3%
Net Profit22.918.1-4.8-21.0%0.0-4.8-21.1%
Net Profit attributable to the Group22.017.2-4.8-21.8%   

The financial statements for the six-month period ended 30 June 2024 were reviewed and adopted by EQUASENS' Board of Directors, chaired by Thierry Chapusot, on 27 September 2024. These interim consolidated financial statements were subject to a limited review by the Statutory Auditors.

_____

Results at 30 June 2024

H1 Current Operating Income / Division2023
reported basis
2024
reported basis
Change / Reported basisExternal growthChange / Like-for-like basis
Pharmagest18.414.1-4.3-23.5%-0.1-4.4-24.0%
Axigate Link4.64.4-0.2-4.9% -0.2-4.9%
e-Connect3.62.5-1.1-29.9% -1.1-29.9%
Medical Solutions1.30.0-1.3-100.0%0.1-1.2-92.5%
Fintech-0.4-0.10.369.3% 0.3-69.3%
Current Operating Income27.520.9-6.6-24.1%0.0-6.7-24.3%
  • PHARMAGEST division: a contraction in earnings reflecting lower sales and reinforced teams in Europe (COI/Sales: 17.2%)

The decline in the Division's operating income is mainly attributable to a reduction in sales in France in the configuration and hardware segment. In a persistently challenging economic environment, the Division continued to focus its commercial strategy on acquiring new customers and regularly rolling out new software and hardware solutions.
Despite this, recurring revenues were bolstered by the combined contribution of new SaaS offerings and contract indexation.
To accelerate the deployment of solutions in Europe, the R&D and sales teams continued to be strengthened.

  • AXIGATE LINK division: the profit margin remains high (COI/Sales: 28.6%)

Strategic investments to support the roll-out of SaaS solutions such as TitanLink for Nursing Homes in Europe, and the extension of homecare services, have temporarily weighed on the Division's results.

  • E-CONNECT division: current operating income declined in response to lower sales (COI/Sales: 45.4%)

As previously reported, H1 2023 sales and earnings were boosted by the announced discontinuation of sales of Application Reader Terminals.
The downturn in business in the first half of 2024 thus reflected the corresponding decline in sales.
Despite this unfavourable environment, the Division demonstrated its ability to adapt by maintaining a healthy profit margin based on tight cost controls.

  • MEDICAL SOLUTIONS division: a year of transition between the Ségur digital healthcare investment programme and a new software solution (COI/Sales: -)

Preparations for the Division's future involving the development of a new software platform and optimising the sales organisation led to significant investments which, in conjunction with lower sales following the end of the Ségur programme roll-out, weighed on the Division's results. Recurring revenues rose 13.7%, resulting in a gross margin of 72.8%.

  • FINTECH division: efforts to stabilise the business paid off in H1, with an improvement in earnings of €0.3m (COI/Sales: -)

Consolidated balance sheet highlights

  • Cash flow after interest and tax maintained a positive trend at €20.8m.
  • Financial investments, through acquisitions as well as capital expenditures, in particular for the EQUASENS private healthcare cloud, continued, with more than €16.0m committed in H1.
  • The net financial surplus at 30/06/2024 of €87.9m takes into account a change in presentation of IFRS 16 lease liabilities and put options for minority shareholders of €10.8m (recognised under other liabilities versus financial liabilities previously).

2024 outlook

  • The Group maintains its forecast for a return to revenue growth starting in the second half of 2024, and an acceleration in 2025 driven by current investments and an economic climate that looks set to improve, particularly for pharmacies in France.
  • The Group will continue to invest in R&D, infrastructure and sales forces in France and Europe in the second half of 2024. And while this will have a temporary impact on profitability in 2024, it should generate a return on investment from 2025 onwards.
  • With a strategy focused on patients and interoperability, the Group is ideally positioned to seize opportunities for external growth in France and Europe.

Financial calendar:

  • 1 October 2024: Presentation of H1 2024 results
  • 7 November 2024: Publication of Q3 2024 revenue
  • 6 February 2025: Publication of f Q4/FY 2024 revenue

About Group Equasens

With more than 1,300 employees, Equasens Group is today a key player in the European healthcare sector, providing software and hardware solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, hospital-at-home programmes, retirement homes, health centres) in both primary and secondary care sectors.

With operations in in France, Germany, Great Britain, Belgium, Ireland, Italy, and Luxembourg, Equasens Group today brings together healthcare professionals within a unique ecosystem in France and Europe benefiting people by making available the very best of technology.

Listed on Euronext Paris™ - Compartment B

Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable
Included in the Euronext Tech Leaders segment and the European Rising Tech label

Eligible for the Deferred Settlement Service (“Service à Réglement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME).
ISIN: FR 0012882389 – Ticker Code: EQS

Get all the news about Equasens Group www.equasens.com and on LinkedIn

CONTACTS

Analyst and Investor Relations:
Chief Administrative and Financial Officer: Frédérique Schmidt
Tel: +33 (0)3 83 15 90 67 - [email protected]

Financial communication agency:
FIN’EXTENSO - Isabelle Aprile

Tel.: +33 (0)6 17 38 61 78 - [email protected]

Attachment


GlobeNewsWire News

Recent Comments